Tadesse K, Benhamou R
Noncoding RNA. 2024; 10(2).
PMID: 38525736
PMC: 10961812.
DOI: 10.3390/ncrna10020017.
Aslani M, Armin F, Abedi A, Keramati E, Ghobadi H
Iran J Basic Med Sci. 2023; 26(10):1120-1130.
PMID: 37736510
PMC: 10510481.
DOI: 10.22038/IJBMS.2023.71915.15627.
Elshafie N, Gribskov M, Lichti N, Sayedahmed E, Childress M, Dos Santos A
Front Oncol. 2023; 13:1238613.
PMID: 37711209
PMC: 10499539.
DOI: 10.3389/fonc.2023.1238613.
Grassilli S, Bertagnolo V, Brugnoli F
Diagnostics (Basel). 2022; 12(9).
PMID: 36140539
PMC: 9497770.
DOI: 10.3390/diagnostics12092139.
Manzoor U, Pandith A, Amin I, Wani S, Sanadhya D, Lone T
J Clin Med. 2022; 11(13).
PMID: 35807118
PMC: 9267497.
DOI: 10.3390/jcm11133834.
microRNA-based diagnostic and therapeutic applications in cancer medicine.
Sempere L, Azmi A, Moore A
Wiley Interdiscip Rev RNA. 2021; 12(6):e1662.
PMID: 33998154
PMC: 8519065.
DOI: 10.1002/wrna.1662.
Recent Advances in Oligonucleotide Therapeutics in Oncology.
Xiong H, Veedu R, Diermeier S
Int J Mol Sci. 2021; 22(7).
PMID: 33804856
PMC: 8036554.
DOI: 10.3390/ijms22073295.
The role of miR-29 family in disease.
Horita M, Farquharson C, Stephen L
J Cell Biochem. 2021; 122(7):696-715.
PMID: 33529442
PMC: 8603934.
DOI: 10.1002/jcb.29896.
Association of miR-4293 rs12220909 polymorphism with cancer risk: A meta-analysis of 8394 subjects.
Liu R, Fu H, Yu Y, Xu Q, Fang J, Ge Q
Medicine (Baltimore). 2020; 99(32):e21364.
PMID: 32769868
PMC: 7593050.
DOI: 10.1097/MD.0000000000021364.
Long non‑coding RNA GAS5 increases the radiosensitivity of A549 cells through interaction with the miR‑21/PTEN/Akt axis.
Chen L, Ren P, Zhang Y, Gong B, Yu D, Sun X
Oncol Rep. 2020; 43(3):897-907.
PMID: 32020207
PMC: 7041238.
DOI: 10.3892/or.2020.7467.
Hypomethylation of MIR-378 5'-flanking region predicts poor survival in young patients with myelodysplastic syndrome.
Wu D, Zhu X, Wen X, Zhang Y, Ma J, Yao D
Mol Genet Genomic Med. 2019; 8(1):e1067.
PMID: 31833222
PMC: 6978398.
DOI: 10.1002/mgg3.1067.
Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
Li P, Dong M, Wang Z
Bosn J Basic Med Sci. 2018; 19(2):146-154.
PMID: 30114378
PMC: 6535391.
DOI: 10.17305/bjbms.2018.2865.
Suppression of miR-21 Expression Inhibits Cell Proliferation and Migration of Liver Cancer Cells by Targeting Phosphatase and Tensin Homolog (PTEN).
Liu H, Cheng L, Cao D, Zhang H
Med Sci Monit. 2018; 24:3571-3577.
PMID: 29807978
PMC: 6003261.
DOI: 10.12659/MSM.907038.
Evaluation of miR-362 Expression in Astrocytoma of Human Brain Tumors.
Kheirollahi M, Moodi M, Ashouri S, Nikpour P, Kazemi M
Adv Biomed Res. 2017; 6:129.
PMID: 29142892
PMC: 5672651.
DOI: 10.4103/2277-9175.216782.
Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
Covach A, Patel S, Hardin H, Lloyd R
Endocr Pathol. 2017; 28(3):207-212.
PMID: 28660408
DOI: 10.1007/s12022-017-9490-7.
MicroRNA-93-5p increases multidrug resistance in human colorectal carcinoma cells by downregulating cyclin dependent kinase inhibitor 1A gene expression.
Wang S, Cao Y, Yang Z, Jiang Z, Cai B, Guo J
Oncol Lett. 2017; 13(2):722-730.
PMID: 28356951
PMC: 5351191.
DOI: 10.3892/ol.2016.5463.
Helicobacter pylori as an oncogenic pathogen, revisited.
Miftahussurur M, Yamaoka Y, Graham D
Expert Rev Mol Med. 2017; 19:e4.
PMID: 28322182
PMC: 6905048.
DOI: 10.1017/erm.2017.4.
miR-142-3p as a biomarker of blastocyst implantation failure - A pilot study.
Borges Jr E, Setti A, Braga D, Geraldo M, Figueira R, Iaconelli Jr A
JBRA Assist Reprod. 2017; 20(4):200-205.
PMID: 28050953
PMC: 5265617.
DOI: 10.5935/1518-0557.20160039.
Diagnostic value of microRNAs in prostate cancer patients with prostate specific antigen (PSA) levels between 2, and 10 ng/mL.
Akbayir S, Muslu N, Erden S, Bozlu M
Turk J Urol. 2016; 42(4):247-255.
PMID: 27909617
PMC: 5125738.
DOI: 10.5152/tud.2016.52463.
Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer.
Wang J, Zhang X, Shi J, Cao P, Wan M, Zhang Q
Oncotarget. 2016; 7(48):78566-78576.
PMID: 27713175
PMC: 5346660.
DOI: 10.18632/oncotarget.12479.